Summary
49M patients are diagnosed with Sepsis and 11M die annually worldwide and costs over €30 billion to treat. This is a senseless tragedy as 80% of sepsis deaths could be prevented with rapid diagnosis and treatment.
SepTec is the groundbreaking, cost-effective technology required to provide the solution.
SepTec is a patent-pending in-vitro diagnostic device that screens blood for the diagnosis of sepsis infection, detecting and identifying pathogens within 15 minutes at very low concentrations (
SepTec is the groundbreaking, cost-effective technology required to provide the solution.
SepTec is a patent-pending in-vitro diagnostic device that screens blood for the diagnosis of sepsis infection, detecting and identifying pathogens within 15 minutes at very low concentrations (
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/967968 |
| Start date: | 01-04-2021 |
| End date: | 31-12-2023 |
| Total budget - Public funding: | 3 455 250,00 Euro - 2 418 675,00 Euro |
Cordis data
Original description
49M patients are diagnosed with Sepsis and 11M die annually worldwide and costs over €30 billion to treat. This is a senseless tragedy as 80% of sepsis deaths could be prevented with rapid diagnosis and treatment.SepTec is the groundbreaking, cost-effective technology required to provide the solution.
SepTec is a patent-pending in-vitro diagnostic device that screens blood for the diagnosis of sepsis infection, detecting and identifying pathogens within 15 minutes at very low concentrations (
Status
SIGNEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
